New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation

J Clin Oncol. 2013 Jul 20;31(21):2749-50. doi: 10.1200/JCO.2013.48.7736. Epub 2013 Jun 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Amyloidosis / blood*
  • Amyloidosis / therapy*
  • Female
  • Humans
  • Immunoglobulin Light Chains / blood*
  • Male

Substances

  • Immunoglobulin Light Chains